Inhibrx Biosciences, Inc. (INBX)
NASDAQ: INBX · Real-Time Price · USD
81.53
0.00 (0.00%)
Feb 5, 2026, 4:00 PM EST - Market open
Inhibrx Biosciences Market Cap
Inhibrx Biosciences has a market cap or net worth of $1.19 billion as of February 6, 2026. Its market cap has increased by 477.25% in one year.
Market Cap
1.19B
Enterprise Value
1.14B
1-Year Change
477.25%
Ranking
Category
Stock Price
$81.53
Market Cap Chart
Since the IPO on May 29, 2024, Inhibrx Biosciences's market cap has increased from $198.24M to $1.19B, an increase of 498.15%. That is a compound annual growth rate of 188.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 4, 2026 | 1.20B | 4.51% |
| Dec 31, 2025 | 1.15B | 415.39% |
| Dec 31, 2024 | 222.93M | 12.46% |
| May 29, 2024 | 198.24M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Savara | 1.29B |
| Capricor Therapeutics | 1.27B |
| Rapport Therapeutics | 1.26B |
| Immatics | 1.25B |
| Taysha Gene Therapies | 1.24B |
| Xeris Biopharma Holdings | 1.17B |
| Pharming Group | 1.16B |
| Inventiva | 1.14B |